*no appropriate 2nd or 3rd level available* please use e07 (respiratory system): "proposed second level coding - voice alteration to capture hoarseness or other vocal changes" livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova's employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects¿ or "malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.Health effect - clinical code :e2311 health effect - clinical code :e2402.
|
It was initially reported that the patient was experiencing laryngitis, throat pain, incision pain, and dyspnea.An update was received that the patient also feels like their voice is more hoarse and requested to have their device explanted.It was later reported that the patient had their vns explanted, per the pt.'s request.The generator would be returned and has not been received to date.No other relevant information has been received to date.
|